|
|
||||||||
From the School of Optometry and Vision Science Program, University of California, Berkeley, California.
PURPOSE. To study retinal dysfunction in diabetes and early nonproliferative diabetic retinopathy (NPDR) using a new method to analyze local multifocal electroretinogram oscillatory potentials (mfOPs).
METHODS. One eye of each of 26 normal subjects, 16 diabetic subjects without retinopathy (NoR), and 16 diabetic subjects with early NPDR was examined. Slow-flash multifocal electroretinograms (sf-mfERGs) were recorded from the central 45°, and stereo fundus photographs of the diabetic eyes were taken. The first-order (K1), induced first-order (K1i), and second-order (K2) response components were extracted from each retinal location, and K1i and K2 were added to create Ks2. Responses from 35 contiguous areas were digitally filtered 90 to 225 Hz to isolate the mfOPs. The signal-to-noise ratio (SNR) of the mfOPs was calculated, and abnormality was defined as SNR below the fifth percentile of the normal subjects.
RESULTS. Combining the K1i and K2 components to form Ks2 before isolation of the mfOPs by digital filtering increased the SNR. Mean Ks2 and K1 mfOP SNRs were abnormal in 25% and 19% of the NoR eyes, respectively, and both were abnormal in 62% of the NPDR eyes. The retinal distributions of the local Ks2 and K1 mfOP abnormalities overlapped, but they differed. Furthermore, local Ks2 mfOP abnormalities were preferentially associated with retinal sites containing NPDR but K1 mfOP abnormalities were not.
CONCLUSIONS. The cells that contribute to the generation of local mfOPs are affected by diabetes and, to a greater degree, by early NPDR. The results suggest that fast adaptive mechanisms influencing the mfOPs are most abnormal at retinal sites containing NPDR.
This article has been cited by other articles:
![]() |
T. K. Ali, S. Matragoon, B. A. Pillai, G. I. Liou, and A. B. El-Remessy Peroxynitrite Mediates Retinal Neurodegeneration by Inhibiting Nerve Growth Factor Survival Signaling in Experimental and Human Diabetes Diabetes, April 1, 2008; 57(4): 889 - 898. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. W. Bronson-Castain, M. A. Bearse Jr, Y. Han, M. E. Schneck, S. Barez, and A. J. Adams Association between Multifocal ERG Implicit Time Delays and Adaptation in Patients with Diabetes Invest. Ophthalmol. Vis. Sci., November 1, 2007; 48(11): 5250 - 5256. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. Antonetti, A. J. Barber, S. K. Bronson, W. M. Freeman, T. W. Gardner, L. S. Jefferson, M. Kester, S. R. Kimball, J. K. Krady, K. F. LaNoue, et al. Diabetic Retinopathy: Seeing Beyond Glucose-Induced Microvascular Disease Diabetes, September 1, 2006; 55(9): 2401 - 2411. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. V. Rangaswamy, W. Zhou, R. S. Harwerth, and L. J. Frishman Effect of Experimental Glaucoma in Primates on Oscillatory Potentials of the Slow-Sequence mfERG Invest. Ophthalmol. Vis. Sci., February 1, 2006; 47(2): 753 - 767. [Abstract] [Full Text] [PDF] |
||||
![]() |
C A Westall Detecting ocular-visual function changes in diabetes Br. J. Ophthalmol., November 1, 2005; 89(11): 1392 - 1393. [Full Text] [PDF] |
||||
![]() |
K. Klemp, B. Sander, P. B. Brockhoff, A. Vaag, H. Lund-Andersen, and M. Larsen The Multifocal ERG in Diabetic Patients without Retinopathy during Euglycemic Clamping Invest. Ophthalmol. Vis. Sci., July 1, 2005; 46(7): 2620 - 2626. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |